Bioxcel TherapeuticsBTAIQ
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 35 institutions reported holding Bioxcel Therapeutics Inc. (BTAIQ) in their 13F filings, up 4 from Q1 2025. 9 opened new positions and 5 sold out. The largest holders were Oaktree Capital Management ($437K), Murchinson Ltd. ($146K) and Diversify Wealth Management, LLC ($102K). 2 famous investors held it, including Howard Marks (0.0% of Oaktree Capital Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Bioxcel Therapeutics Inc.
- CUSIP
- 09075P204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $770K |
| Exits | 5 | $73K |
All 13F filers, Q1 2025 → Q2 2025: 399,818 shares bought and 160,712 shares sold, net +239,106 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Oaktree Capital Management | 0.01% | New | 241,188 | $437K |
| Murchinson Ltd. | 0.08% | Reduce -40.8% | 80,618 | $146K |
| Diversify Wealth Management, LLC | 0.01% | New | 15,000 | $102K |
| Oaktree Fund Advisors, LLC | 0.14% | New | 42,913 | $78K |
| UBS Group AG | 0.00% | Reduce -60.8% | 39,882 | $72K |
| Geode Capital Management, LLC | 0.00% | Add +27.7% | 28,182 | $51K |
| Jones Financial Companies LLLP | 0.00% | New | 26,000 | $46K |
| HighTower Advisors, LLC | 0.00% | New | 24,600 | $45K |
| XTX Topco Ltd | 0.00% | New | 23,424 | $42K |
| Beacon Pointe Advisors, LLC | 0.00% | No change | 18,845 | $34K |
| Vanguard Group Inc. | 0.00% | No change | 18,824 | $34K |
| BlackRock, Inc. | 0.00% | Reduce -23.5% | 17,778 | $32K |
| Wells Fargo & Company | 0.00% | Add +37.6% | 16,919 | $31K |
| Citadel Advisors | 0.00% | New | 11,378 | $21K |
| Osaic Holdings, Inc. | 0.00% | Add +168.2% | 5,053 | $9K |
| Morgan Stanley | 0.00% | Reduce -10.5% | 1,580 | $3K |
| Bank of America Corp. | 0.00% | Add +1.8% | 1,547 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +801.3% | 1,370 | $2K |
| Group One Trading LLC | 0.00% | No change | 1,273 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +3.3% | 879 | $2K |
| AllSquare Wealth Management LLC | 0.00% | No change | 175 | $317 |
| Washington Trust Advisors, Inc. | 0.00% | No change | 160 | $290 |
| Raymond James Financial Inc. | 0.00% | New | 125 | $226 |
| Parkside Financial Bank & Trust | 0.00% | No change | 112 | $203 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | No change | 103 | $186 |
| JPMorgan Chase & Co. | 0.00% | Reduce -61.2% | 45 | $81 |
| BNP Paribas Financial Markets | 0.00% | No change | 44 | $80 |
| NewEdge Advisors, LLC | 0.00% | No change | 31 | $57 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 21 | $38 |
| Barclays PLC | 0.00% | Reduce -99.6% | 8 | $14 |
| National Bank of Canada | 0.00% | Reduce -77.8% | 6 | $11 |
| Danske Bank A/S | 0.00% | No change | 3 | $5 |
| US Bancorp \de | 0.00% | No change | 1 | $2 |
| Elevation Point Wealth Partners, LLC | 0.00% | New | 1 | $2 |
| Federation des caisses Desjardins du Quebec | 0.00% | Reduce -66.7% | 1 | $2 |
"% of holder's portfolio" is BTAIQ's weight in each manager's 13F, not the share of Bioxcel Therapeutics Inc. the manager owns.